Percentage of women age 21-64 who had cervical cytology performed every three years, or women age 30-64 who had cervical cytology/human papillomavirus (HPV) co-testing performed every five years. The Cervical Cancer Screening measure was revised in 2019 and is not comparable to prior years. This measure was aligned with a specific clinical measure, CMS124v10, used by the Centers for Medicare and Medicaid Services. For more information about this eCQM, see https://ecqi.healthit.gov/ecqm/ec/2022/cms124v10.
Uniform Data System, 2022 (Health Resources and Services Administration)
Next Planned Update
Where It’s Found in the UDS Mapper
Health Center Administrative Location Information Card Deck: Quality